tradingkey.logo

Nexgel Inc

NXGL

2.545USD

-0.025-0.97%
Horarios del mercado ETCotizaciones retrasadas 15 min
19.48MCap. mercado
PérdidaP/E TTM

Nexgel Inc

2.545

-0.025-0.97%
Más Datos de Nexgel Inc Compañía
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. It also specializes in eye and eyelash consumer products.
Información de la empresa
Símbolo de cotizaciónNXGL
Nombre de la empresaNexgel Inc
Fecha de salida a bolsaDec 22, 2021
Director ejecutivoMr. Adam Levy
Número de empleados19
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 22
Dirección2150 Cabot Blvd West,
CiudadLANGHORNE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal19047
Teléfono12157028550
Sitio Webhttps://nexgel.com/
Símbolo de cotizaciónNXGL
Fecha de salida a bolsaDec 22, 2021
Director ejecutivoMr. Adam Levy
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Steven Mark Glassman
Mr. Steven Mark Glassman
Independent Chairman of the Board
Independent Chairman of the Board
156.66K
+0.03%
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
106.66K
--
Mr. Joseph F. (Joe) McGuire
Mr. Joseph F. (Joe) McGuire
Chief Financial Officer
Chief Financial Officer
4.08K
--
Mr. Nachum Stein
Mr. Nachum Stein
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Mr. Adam Levy
Mr. Adam Levy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Scott R. Henry
Mr. Scott R. Henry
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Steven Mark Glassman
Mr. Steven Mark Glassman
Independent Chairman of the Board
Independent Chairman of the Board
156.66K
+0.03%
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
106.66K
--
Mr. Joseph F. (Joe) McGuire
Mr. Joseph F. (Joe) McGuire
Chief Financial Officer
Chief Financial Officer
4.08K
--
Mr. Nachum Stein
Mr. Nachum Stein
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Mr. Adam Levy
Mr. Adam Levy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 23 de may
Actualizado: vie., 23 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Stein (John Nachum)
6.03%
Levy (Adam R)
4.90%
Evernest Financial Advisors, LLC
3.67%
Glassman (steven mark)
2.05%
Henry (Scott Robert)
1.69%
Other
81.66%
Accionistas
Accionistas
Proporción
Stein (John Nachum)
6.03%
Levy (Adam R)
4.90%
Evernest Financial Advisors, LLC
3.67%
Glassman (steven mark)
2.05%
Henry (Scott Robert)
1.69%
Other
81.66%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
16.11%
Investment Advisor
6.21%
Investment Advisor/Hedge Fund
1.61%
Hedge Fund
1.07%
Family Office
0.14%
Venture Capital
0.13%
Other
74.72%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
34
1.92M
25.13%
-119.08K
2025Q1
37
2.17M
29.57%
+164.76K
2024Q4
32
1.98M
26.34%
+256.49K
2024Q3
30
1.74M
25.65%
+126.36K
2024Q2
29
1.63M
25.29%
+39.41K
2024Q1
28
1.57M
26.08%
+59.90K
2023Q4
28
1.51M
25.63%
-46.18K
2023Q3
30
1.53M
26.03%
-38.00K
2023Q2
29
1.53M
25.96%
+67.69K
2023Q1
26
1.40M
25.19%
+48.62K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Stein (John Nachum)
461.46K
6.03%
-48.20K
-9.46%
Apr 30, 2025
Levy (Adam R)
375.34K
4.9%
-6.00K
-1.57%
Jun 11, 2025
Evernest Financial Advisors, LLC
224.67K
2.94%
+224.67K
--
Mar 31, 2025
Glassman (steven mark)
156.66K
2.05%
+40.00
+0.03%
Apr 30, 2025
Henry (Scott Robert)
129.05K
1.69%
-3.00K
-2.27%
Jun 13, 2025
Zeldis (Jerome B)
106.66K
1.39%
--
--
Apr 30, 2025
Morgan Stanley Smith Barney LLC
87.80K
1.15%
--
--
Mar 31, 2025
Renaissance Technologies LLC
81.63K
1.07%
-76.70K
-48.44%
Mar 31, 2025
Geode Capital Management, L.L.C.
66.45K
0.87%
+6.30K
+10.48%
Mar 31, 2025
The Vanguard Group, Inc.
50.10K
0.65%
+127.00
+0.25%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI